生命第一年内麻疹、风疹和腮腺炎免疫持续时间研究
该研究在西班牙单中心前瞻性观察146对母婴,检测母亲及婴儿出生时和3、6、9、12月龄的麻疹、风疹、腮腺炎抗体。结果显示婴儿抗体滴度在3月龄后下降,6月龄时三种疾病抗体均未检出;建议可考虑将MMR疫苗提前至9月龄接种,但需更大规模人群研究证实。
要点
- 婴儿母体抗体在3月龄后下降,6月龄时麻疹、风疹、腮腺炎抗体均未检出。
- 母亲抗体阳性率分别为麻疹78.4%、风疹86.9%、腮腺炎67.1%。
- 研究提示可考虑将MMR疫苗提前至9月龄,但需更大规模研究确认。
核心结论
- 在当前流行病学条件下,婴儿经胎盘获得的麻疹、风疹和腮腺炎抗体快速消失,6月龄时已检测不到抗体。
- 研究提示将MMR疫苗接种提前至9月龄可能是合理的,但需更大规模人群研究证实。
研究设计与样本
- 纳入146对母婴,采集母亲血清和干血斑样本,婴儿出生时及3、6、9、12月龄干血斑样本。
- 采用标准化定量方法检测麻疹、风疹和腮腺炎病毒抗体水平。
主要发现
- 母亲抗体阳性率:麻疹78.4%、风疹86.9%、腮腺炎67.1%。
- 婴儿抗体滴度在3月龄后下降,6月龄时三种疾病抗体均未检出。
- 1981年前后出生母亲所生婴儿在第一年内抗体滴度无统计学显著差异。
临床怎么用
- 监测婴儿母体抗体消失情况,评估MMR疫苗提前接种的可行性。
- 在制定免疫规划时考虑当前流行病学条件下母体抗体持续时间的变化。
局限性
- 单中心研究,样本量有限,需更大规模人群研究确认结果。
- 研究未报告抗体滴度的具体数值及统计学检验细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION AND OBJECTIVES: The MMR vaccine was included in the official vaccination schedule in Spain in 1981. Currently, most women of childbearing age are vaccinated and have not been naturally infected. Several studies have shown that vaccinated women have a lower antibody concentration than that achieved after natural infection, and a shorter duration of transplacentally acquired antibodies in their children. The objective of this study was to determine the antibody titer in mothers and their infants at birth and throughout the first year of life under current epidemiological circumstances. MATERIAL AND METHODS: Single-center, observational, descriptive and prospective study conducted between October 2013 and December 2014. One sample of serum and another of a dried blood spot on filter paper were taken from each mother. Dried blood spot samples on filter paper were taken from the children at birth, and at 3, 6, 9 and 12 months. In all the samples, levels of antibodies to the measles, rubella and mumps viruses were measured using standardized quantitative assays. RESULTS: 146 mother-child pairs were included. 78.4%, 86.9% and 67.1% of mothers had antibodies to measles, rubella and mumps, respectively. A decrease in the antibody titer in children was observed after 3 months, and no antibodies against the three diseases were detected by the age of 6 months. Comparisons revealed no statistically significant differences between the antibody titers of children of mothers born before or after 1981 during the first year of their life. DISCUSSION: The rapid loss of transplacentally acquired antibodies against measles, rubella and mumps, under current epidemiological conditions, suggests that bringing the MMR vaccination forward to 9 months might be justified. Larger population studies are needed to confirm these results.
引用
- Cilleruelo MJ, Fernández-García A, Villaverde S, et al. Duration of immunity to measles, rubella and mumps during the first year of life. Vaccine. 2019. PMID: 31151799. doi:10.1016/j.vaccine.2019.05.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。